Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Short-Term Debt issuances (2021 - 2024)

Firefly Neuroscience has reported Short-Term Debt issuances over the past 6 years, most recently at -$200000.0 for Q2 2024.

  • Quarterly results put Short-Term Debt issuances at -$200000.0 for Q2 2024, changed N/A from a year ago — trailing twelve months through Jun 2024 was -$200000.0 (down 120.0% YoY), and the annual figure for FY2023 was $575000.0, up 35.29%.
  • Short-Term Debt issuances for Q2 2024 was -$200000.0 at Firefly Neuroscience, down from $575000.0 in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for AIFF hit a ceiling of $575000.0 in Q1 2023 and a floor of -$350000.0 in Q2 2021.
  • Median Short-Term Debt issuances over the past 4 years was $425000.0 (2022), compared with a mean of $190000.0.